Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Prexton therapeutics

Explore full profile

Integrates molecular, behavioral and chemistry technologies to address Parkinson’s disease and other brain disorders

Oss, NetherlandsFounded 2012Biotech & Life Sciences
Valuation $1–2.5B Last recorded · 2018
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Prexton therapeutics and the history behind them.

About Prexton therapeutics

Prexton Therapeutics is dedicated to developing innovative drugs aimed at improving the quality of life for individuals suffering from brain disorders and other diseases. The company specializes in designing novel mGluR4 compounds, which are a new class of treatments for these conditions. Prexton Therapeutics primarily serves patients with neurological disorders, operating within the pharmaceutical and biotech market. The business model revolves around research and development of proprietary compounds, which are then licensed or sold to larger pharmaceutical companies for further development and commercialization. Revenue is generated through licensing agreements, milestone payments, and royalties from sales of the developed drugs.

Source: Dealroom company data

At a glance

Founded
2012
Headquarters
Oss, Netherlands
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tier

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Eclosion

Series A4 investors entered at this stage

  • Ysios Capital
  • M Ventures
  • Seroba Life Sciences
  • Forbion Capital Partners

Series B and later2 investors entered at this stage

  • Seroba Life Sciences
  • Forbion Capital Partners

Talent

Book a demo to see the people
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇳🇱 Netherlands · Oss HQ
Book a demo for the full country breakdown
Web traffic by country
1.1K monthly visits
across markets
🇺🇸 United States45.5%
🇲🇪 Montenegro18.2%
🇩🇪 Germany18.2%
🇧🇪 Belgium9.1%
Top 4 markets shown

Patents

Estimated portfolio value
$26k

2 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Prexton therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Prexton therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles